# Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition

> **NCT01582217** · — · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 318 (actual)

## Conditions studied

- Percutaneous Coronary Intervention
- Dual Antiplatelet Therapy
- Aspirin
- Clopidogrel

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01582217
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 318 (ACTUAL)
- **Last updated:** 2015-12-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01582217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01582217, "Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01582217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*